The off-label use of ketamine to treat chronic pain is not supported by scientific evidence, a new Cochrane review has found.

A major Cochrane review found no convincing evidence that ketamine or similar NMDA-blocking drugs improve chronic non-cancer ...

A sweeping review of 67 trials has cast doubt on the use of ketamine and similar NMDA receptor antagonists for chronic pain relief. While ketamine is frequently prescribed off-label for conditions ...

An extensive analysis shows scant evidence that ketamine or other NMDA receptor agonists reduce chronic noncancer pain but ...

Researchers cautioned that the existing evidence base is too poor to draw any solid conclusions on whether ketamine can help ...

But Tankha, her pain specialist, wouldn’t give up. He suggested Ryan try ketamine infusions, which he says have been used as a treatment for chronic pain since the 1980s.

Tankha says he is hoping to raise enough money to properly study ketamine’s utility for chronic pain. “The binding to the receptor is over in maybe 10 to 15 minutes, maybe a couple hours, if you’re ...

Ketamine acts quickly in the body, and it is also cleared quickly, within hours. Yet Ryan and others who use it for chronic pain say the relief they get after their treatments lasts for months.

Tankha says he is hoping to raise enough money to properly study ketamine’s utility for chronic pain. “The binding to the receptor is over in maybe 10 to 15 minutes, maybe a couple hours, if ...

Ketamine acts quickly in the body, and it is also cleared quickly, within hours. Yet Ryan and others who use it for chronic pain say the relief they get after their treatments lasts for months.

Tankha says he is hoping to raise enough money to properly study ketamine’s utility for chronic pain. “The binding to the receptor is over in maybe 10 to 15 minutes, maybe a couple hours, if ...